Genetic association analysis of COPD candidate genes with bronchodilator responsiveness

Respiratory Medicine

Volumn 103, Issue 4, 2009, Pages 552-557

  Kim, Woo Jin ^a,b   Hersh, Craig P ^a   DeMeo, Dawn L ^a   Reilly, John J ^a   Silverman, Edwin K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Kangwon National University   (South Korea)

Author keywords

Association analysis; Bronchodilator responsiveness; Chronic obstructive pulmonary disease; Genetics

Indexed keywords

ADENOSINE DEAMINASE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE P1; MEMBRANE PROTEIN; PROTEIN ADARB2; PROTEIN EPHX1; PROTEIN SERPINE2; PROTEIN SFTPB; SALBUTAMOL; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CAUCASIAN; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SPIROMETRY; UNITED STATES; YOUNG ADULT;

ADULT; AGED; ALBUTEROL; BOSTON; BRONCHODILATOR AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; YOUNG ADULT;

EID: 60649118728     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.025     Document Type: Article

References (33)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 6 (2007) 532-555
2. Anthonisen N.R., Lindgren P.G., Tashkin D.P., et al. Bronchodilator response in the Lung Health Study over 11 yrs. Eur Respir J 26 1 (2005) 45-51
3. Lehmann S., Bakke P.S., Eide G.E., Humerfelt S., and Gulsvik A. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a β2-agonist. Pulm Pharmacol Ther 19 4 (2006) 272-280
4. Schermer T., Heijdra Y., Zadel S., et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 101 6 (2007) 1355-1362
5. Miller M., Ramsdell J., Friedman P.J., Cho J.Y., Renvall M., and Broide D.H. Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol 120 5 (2007) 1118-1125
6. Celedon J.C., Speizer F.E., Drazen J.M., et al. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD. Eur Respir J 14 5 (1999) 1009-1014
7. Zhang X., Mahmudi-Azer S., Connett J., et al. Association of Hck genetic polymorphisms with gene expression and COPD. Hum Genet 120 5 (2007) 681-690
8. Hizawa N., Makita H., Nasuhara Y., et al. β2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 132 5 (2007) 1485-1492
9. Hersh C.P., DeMeo D.L., Lange C., et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 33 1 (2005) 71-78
10. Celedon J.C., Lange C., Raby B.A., et al. The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 13 15 (2004) 1649-1656
11. DeMeo D., Mariani T., Lange C., et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 78 2 (2006) 253-264
12. Matheson M., Ellis J., Raven J., Johns D., Walters E., and Abramson M. β2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J Hum Genet 51 11 (2006) 943
13. Hegab A.E., Sakamoto T., Saitoh W., et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 126 6 (2004) 1832-1839
14. Hall I.P., and Sayers I. Pharmacogenetics and asthma: false hope or new dawn?. Eur Respir J 29 6 (2007) 1239-1245
15. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 21 (2003) 2059-2073
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Repir Crit Care Med 152 (1995) 1107-1136
17. DeMeo D.L., Hersh C.P., Hoffman E.A., et al. Genetic determinants of emphysema distribution in the National Emphysema Treatment Trial. Am J Respir Crit Care Med 176 1 (2007) 42-48
18. Silverman E.K., Chapman H.A., Drazen J.M., et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157 6 (1998) 1770-1778
19. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat Genet 37 11 (2005) 1217-1223
20. The International HapMap Project. Nature 426 (2003) 789-796
21. Hersh C.P., DeMeo D.L., Lazarus R., et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 9 (2006) 977-984
22. Hersh C., DeMeo D., Reilly J., and Silverman E. Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery. Respir Res 8 1 (2007) 59
23. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 2 (2002) 425-434
24. Lange C., DeMeo D., Silverman E., Weiss S., and Laird N. PBAT: tools for family-based association studies. Am J Hum Genet 74 2 (2004) 367-369
25. National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest 116 6 (1999) 1750-1761
26. Smith C.A., and Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350 9078 (1997) 630-633
27. Cheng S.L., Yu C.J., Chen C.J., and Yang P.C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 23 6 (2004) 818-824
28. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., and Pare P.D. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 163 2 (2001) 469-473
29. Borczuk A.C., Gorenstein L., Walter K.L., Assaad A.A., Wang L., and Powell C.A. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163 5 (2003) 1949-1960
30. Zhu G., Warren L., Aponte J., et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 176 2 (2007) 167-173
31. Thakkinstian A., McEvoy M., Minelli C., et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a huge review. Am J Epidemiol 162 3 (2005) 201-211
32. Hawkins G.A., Weiss S.T., and Bleecker E.R. Clinical consequences of ADRB2 polymorphisms. Pharmacogenomics 9 3 (2008) 349-358
33. Pellegrino R., Viegi G., Brusasco V., et al. Interpretative strategies for lung function tests. Eur Respir J 26 5 (2005) 948-968